Minnesota Colorectal Cancer Research Foundation logo

2026 MCCRF Symptom and Survivorship Research Grant

Minnesota Colorectal Cancer Research Foundation

Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

Foundation

Deadline history & next window

Cycle
Annual
Tracked since
April 2026

Source: the cycle recorded on this listing. Confirm dates with the funder.

Overview

Geographic Scope: Minnesota, United States

Focus Areas: Research on symptoms and survivorship issues in colorectal cancer patients, including quality of life, long-term health outcomes, and symptom management

Background: MCCRF funds research addressing the often-overlooked consequences of colorectal cancer that persist after treatment, including fatigue, shortness of breath, reduced physical capacity, and other survivorship challenges.

Contact Information

  • Application/Administrative Inquiries: sandy.m@minnesotacolorectal.org
  • Scientific/Grant Requirements Questions: star0044@umn.edu

What Minnesota Colorectal Cancer Research Foundation actually gave

Source: IRS Form 990, 2024

Grants in 2024
2
Total given
$375K
Median grant
$188K
Range
$75K–$300K
  • By dollars: Minnesota 100%. Top recipient cities: Minneapolis, MN.

Example grants

  • University of Minnesota Foundation · Minneapolis, MN

    Support research on improved treatment of colon and rectal cancer

    $300K

  • Mayo Clinic Foundatoin · Minneapolis, MN

    Targeting sos signaling in colorectal cancer

    $75K

IRS Form 990, 2024. Amounts as reported by the funder. Full 990 history →

Focus Areas & Funding Uses

Fields of Work

  • Science research
  • Cancer

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for 2026 MCCRF Symptom and Survivorship Research Grant?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found 2026 MCCRF Symptom and Survivorship Research Grant. Now let's win it.

Start writing